![]() |
||||||
Guest Editorial: Participatory Health - The Emerging Era of Engaged Health Consumers
By Jane Sarasohn-Kahn, THINK-Health and
Health Populi blog
The most underutilized resource in health care isn't
digital imaging or prescription drugs or even highly
touted health information technology. It's the patient,
stupid.
A growing cadre of health citizens is learning to more
closely engage with the U.S. health system and
participate in their own health care. Neglect them at
your peril.
This isn't your brother's consumer-directed health
care. Welcome to the new era of connected,
participatory health care. We DIY photo development,
travel and financial planning, and home makeovers.
Health care is following these everyday DIY activities
driven by several factors.
Health Care Marketing Research in 2010 -
What's Going to Be Hot and What's Not
Health care marketing research experienced a
number of changes and trends in 2009, some subtle
and some not so subtle.
Clearly, the trend toward staff
reductions and significant budget cuts continued
unabated. Against this backdrop of reduction,
however, some new marketing research and trends
arose, such as an even greater research focus in the
area of oncology as well as an increasing interest in
social marketing. In terms of methodologies
employed, 2009 brought a movement back toward a
reliance on qualitative marketing research, especially
depth interviews, and a decrease in quantitative work.
Last, but certainly not
least, this year we became more mindful of federal
and state regulations governing our activities.
What does all this mean for health care marketing
research in 2010?
Did You Miss the November Issue of Topline?
Click
here to read the issue, which
includes:
Topline
archive is available. Skim the
directory and select
articles you missed. Access subscriber
opt-in/comment form.
|
December 2009
Here We Go Again As most of you know, I've been in the pharmaceutical marketing research business for almost 40 years. During this time, I have seen history repeat itself over and over, and it would appear from some of the research requests we get from clients that we are about to enter another one of those periods. In watching the pharmaceutical industry's behavior over the years, I have been reminded of the old saying about lawyers' handling of cases. "When the facts are on your side, shout the facts. When the law is on your side, shout the law. When nothing is on your side, just shout. " And so it is in the pharmaceutical industry... Richard B. Vanderveer, Ph.D. CEO, GfK Healthcare "Network" with GfK Healthcare Like the content you receive in Topline?
Then join GfK Healthcare's virtual communities on popular social networking sites like Facebook, LinkedIn and Twitter! |
|||||
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||||